#USA #Baltimore #Cancer Treatment #Proton Therapy #Maryland Proton

Maryland Proton Treatment Center Marks a Decade of Healing

On February 23, 2026, the Maryland Proton Treatment Center (MPTC) proudly celebrates a significant historical milestone: ten years of dedicated service in the fight against cancer using breakthrough proton therapy. The center, located at 850 W. Baltimore St., Baltimore, Maryland, has established itself as a pioneer in medical care, providing advanced treatment options that prioritize patient well-being.

A Unique Treatment Approach

Established in 2016, MPTC emerged at a critical time when there were just 13 proton centers nationwide, none of which were situated in Maryland, Washington D.C., or Northern Virginia. This ambitious venture not only filled a geographical gap but also introduced cutting-edge technology to the region. Over the past ten years, the center has thrived as a critical player in the national landscape of over 45 proton centers, continually expanding access and treatment availability.

Proton therapy is a form of radiation therapy that uses protons to precisely target tumors, sparing surrounding healthy tissue and organs. Unlike traditional forms of radiation, which often leave patients vulnerable to collateral damage, proton therapy minimizes side effects, significantly improving recovery outcomes. MPTC has successfully treated over 6,000 patients, with more than 90% of them being residents of Maryland. Its well-coordinated approach, developed in partnership with the University of Maryland Department of Radiation Oncology, has led to participation in 53 clinical trials and enrollment of over 2,544 patients in the Proton Collaborative Group registry.

Celebrating Patient and Staff Contributions

To commemorate this momentous occasion, MPTC is hosting a day of appreciation for its staff and patients, filled with gifts, treats, and heartfelt recognition of their journeys and contributions. The dedication of both teams has been pivotal in cultivating an environment of care and compassion, ensuring each patient's treatment plan is uniquely tailored to their needs.

Commitment to Excellence

MPTC is also recognized for its notable cost-neutral rate structure for treatment, which aligns proton therapy costs with traditional photon radiation. This approach has resulted in an impressive insurance approval rate exceeding 90%, enabling a greater range of patients to access the lifesaving therapies they require.

The center's affiliation with the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center further strengthens its mission, combining world-class research with compassionate patient care. Through innovative treatment plans and state-of-the-art pencil beam technology, MPTC continues to set a standard for excellence in cancer care.

Looking Forward

As MPTC celebrates its achievements, its vision for the future remains rooted in continuous improvement, outreach, and education about proton therapy. The impact of its work extends beyond treatment, as the center actively engages in community efforts to raise awareness about cancer treatment options, particularly targeting underserved populations.

In conclusion, the Maryland Proton Treatment Center stands not only as a beacon of hope but also as a testament to the dedication and resilience of an entire community fighting against cancer. The next decade promises exciting advancements in technology, research, and patient care as MPTC continues its noble pursuit of innovation in cancer treatment.

This anniversary celebration on February 23rd is not just a reflection of ten years past; it is a commitment to enduring excellence and hope for all those affected by cancer.